Influence of the lactose grade within dry powder formulations of fluticasone propionate and terbutaline sulphate

被引:17
|
作者
Le, V. N. P. [1 ]
Bierend, H. [2 ]
Robins, E. [3 ]
Steckel, H. [2 ]
Flament, M. P. [1 ]
机构
[1] Univ Lille Nord France, Coll Pharm, INSERM 1008, F-59006 Lille, France
[2] Univ Kiel, Inst Pharmaceut, D-24118 Kiel, Germany
[3] APTAR Pharma, F-27100 Le Vaudreuil, France
关键词
Dry powder inhalation; Lactose; Physicochemical properties; Adhesion; Aerodynamic behaviour; Inverse gas chromatography; INVERSE GAS-CHROMATOGRAPHY; SALBUTAMOL SULFATE; INHALATION FORMULATIONS; INTERACTIVE MIXTURES; SURFACE-ENERGY; IN-VITRO; PERFORMANCE; CARRIER; DISPERSION; FUNCTIONALITY;
D O I
10.1016/j.ijpharm.2011.10.030
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dry powder formulations are often composed of fine drug particles and coarser carrier particles, typically alpha-lactose monohydrate. However, the performance of a powder formulation may be highly dependent on the lactose quality and source. This study investigated the characteristics of lactose that influence the drug-to-carrier interaction and the performance of lactose-based dry powder inhaler formulations. The selected lactoses differed in the preparation processes and the content of fine lactose particles. Efficiency testing was done using fluticasone propionate and terbutaline sulphate as model drugs. Inverse gas chromatography was used to determine the surface heterogeneity distribution of different energy sites of the lactose and to understand the mechanism by which the fine carrier particles can improve the performance of dry powder inhalers. To assess the adhesion of respirable-sized drug to carrier particles, a simple method was developed based on aspiration and considering the whole blend as it is used in dry powder inhalers. When the percentage of fine lactose is high, a lower quantity of drug adheres to the lactose and/or the adhesion force is also lower. This was confirmed by the aerosolization assays done in the TSI (twin stage impinger). A correlation was observed between adhesion characteristics and inertial impaction. For both drugs, the fine particle fractions were highest in blends that present a greater proportion of lactose fine particles. A fairly good correlation between the fine particle fractions of both drugs and the peak max value and the AUC (area under curve) were found by inverse gas chromatography. With higher fine particle fraction values, which correspond to higher content of fines, the peak maxima determined by inverse gas chromatography were shifted to higher adsorption potentials, which supports the agglomeration hypothesis. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:75 / 82
页数:8
相关论文
共 50 条
  • [41] COARSE LACTOSE PARTICLES AS DISPERSION ENHANCERS DURING AEROSOLIZATION OF DRY POWDER FORMULATIONS
    Yost, Edward
    Puri, Vibha
    Narang, Ajit
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2018, 31 (02) : A18 - A18
  • [42] DEFINING CRITICAL MATERIAL ATTRIBUTES OF MICRONISED LACTOSE IN DRY POWDER INHALER FORMULATIONS
    Bansal, Harsimran Singh
    Hebbink, Gerald
    Shur, Jagdeep
    Price, Robert
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2015, 28 (04) : A6 - A6
  • [43] Gender and age risks for hoarseness and dysphonia with use of a dry powder fluticasone propionate inhaler in asthma
    Ishizuka, Tamotsu
    Hisada, Takeshi
    Aoki, Haruka
    Yanagitani, Noriko
    Kaira, Kyoichi
    Utsugi, Mitsuyoshi
    Shimizu, Yasuo
    Sunaga, Noriaki
    Dobashi, Kunio
    Mori, Masatomo
    ALLERGY AND ASTHMA PROCEEDINGS, 2007, 28 (05) : 550 - 556
  • [44] Treatment of Asthmatic Patients with Fluticasone Propionate and Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhalers Compared with Placebo: Patient-Reported Outcomes and Quality of Life
    Sher, Lawrence
    Yiu, Gloria
    Sakov, Anat
    Liu, Siyu
    Caracta, Cynthia
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB97 - AB97
  • [45] Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate
    Wardlaw, A
    Larivee, P
    Eller, J
    Cockcroft, DW
    Ghaly, L
    Harris, AG
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2004, 93 (01) : 49 - 55
  • [46] INVESTIGATING THE EFFECT OF THE FORCE CONTROL AGENT MAGNESIUM STEARATE IN FLUTICASONE PROPIONATE DRY POWDER INHALED FORMULATIONS WITH SINGLE PARTICLE AEROSOL MASS SPECTROMETRY (SPAMS)
    Jetzer, M.
    Morrical, B.
    Schneider, M.
    Imanidis, G.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2017, 30 (04) : A10 - A11
  • [47] Patient-Reported Outcomes and Quality of Life Improved with Fluticasone Propionate and Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhalers Versus Placebo in Patients with Persistent Asthma
    Raphael, Gordon
    Yiu, Gloria
    Sakov, Anat
    Liu, Siyu
    Caracta, Cynthia
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB10 - AB10
  • [48] Effect of compression pressure on inhalation grade lactose as carrier for dry powder inhalations
    Raut, Neha Sureshrao
    Jamaiwar, Swapnil
    Umekar, Milind Janrao
    Kotagale, Nandkishor Ramdas
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2016, 6 (01) : 39 - 46
  • [49] An advanced and detailed in vitro validation procedure for the radiolabeling of carrier-free terbutaline sulphate dry powder
    Walker, PS
    Petterson, GL
    Bondesson, E
    Conway, JH
    JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2001, 14 (02): : 227 - 236
  • [50] Inhalable Lactose-Based Dry Powder Formulations of Low Molecular Weight Heparin
    Bai, Shuhua
    Gupta, Vivek
    Ahsan, Fakhrul
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2010, 23 (02) : 97 - 104